| Product Code: ETC6738136 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Blood Cancer Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Blood Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 China Blood Cancer Market - Industry Life Cycle |
3.4 China Blood Cancer Market - Porter's Five Forces |
3.5 China Blood Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Blood Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 China Blood Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 China Blood Cancer Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 China Blood Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 China Blood Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 China Blood Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Blood Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of blood cancer in China |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Advancements in medical technology and treatment options |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in rural areas |
4.3.2 High cost of specialized blood cancer treatments |
4.3.3 Stringent regulatory approval processes for new therapies |
5 China Blood Cancer Market Trends |
6 China Blood Cancer Market, By Types |
6.1 China Blood Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Blood Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Blood Cancer Market Revenues & Volume, By Leukaemia, 2021- 2031F |
6.1.4 China Blood Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 China Blood Cancer Market Revenues & Volume, By Myeloma, 2021- 2031F |
6.2 China Blood Cancer Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 China Blood Cancer Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 China Blood Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.2.4 China Blood Cancer Market Revenues & Volume, By Stem Cell Transplant, 2021- 2031F |
6.2.5 China Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Blood Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 China Blood Cancer Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.3.3 China Blood Cancer Market Revenues & Volume, By Bone Marrow Biopsy, 2021- 2031F |
6.3.4 China Blood Cancer Market Revenues & Volume, By Urine Tests, 2021- 2031F |
6.3.5 China Blood Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.4 China Blood Cancer Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 China Blood Cancer Market Revenues & Volume, By Capsule, 2021- 2031F |
6.4.3 China Blood Cancer Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.4 China Blood Cancer Market Revenues & Volume, By Injections, 2021- 2031F |
6.4.5 China Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Blood Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 China Blood Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 China Blood Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 China Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Blood Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 China Blood Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China Blood Cancer Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 China Blood Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 China Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 China Blood Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 China Blood Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 China Blood Cancer Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 China Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 China Blood Cancer Market Revenues & Volume, By Others, 2021- 2031F |
7 China Blood Cancer Market Import-Export Trade Statistics |
7.1 China Blood Cancer Market Export to Major Countries |
7.2 China Blood Cancer Market Imports from Major Countries |
8 China Blood Cancer Market Key Performance Indicators |
8.1 Number of patients diagnosed with blood cancer annually in China |
8.2 Adoption rate of innovative blood cancer treatments |
8.3 Rate of successful outcomes in blood cancer treatment |
8.4 Number of research studies and clinical trials conducted in the field of blood cancer in China |
8.5 Patient satisfaction and quality of life improvements post-treatment. |
9 China Blood Cancer Market - Opportunity Assessment |
9.1 China Blood Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Blood Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 China Blood Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 China Blood Cancer Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 China Blood Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 China Blood Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 China Blood Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Blood Cancer Market - Competitive Landscape |
10.1 China Blood Cancer Market Revenue Share, By Companies, 2024 |
10.2 China Blood Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here